Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines.
Khetan R, Dharmayanti C, Gillam TA, Kübler E, Klingler-Hoffmann M, Ricciardelli C, Oehler MK, Blencowe A, Garg S, Albrecht H.
Khetan R, et al.
Cancers (Basel). 2022 May 10;14(10):2362. doi: 10.3390/cancers14102362.
Cancers (Basel). 2022.
PMID: 35625966
Free PMC article.
Review.